162 related articles for article (PubMed ID: 17699848)
1. The cancer/testis antigen melanoma-associated antigen-A3/A6 is a novel target of fibroblast growth factor receptor 2-IIIb through histone H3 modifications in thyroid cancer.
Kondo T; Zhu X; Asa SL; Ezzat S
Clin Cancer Res; 2007 Aug; 13(16):4713-20. PubMed ID: 17699848
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor 2 and estrogen control the balance of histone 3 modifications targeting MAGE-A3 in pituitary neoplasia.
Zhu X; Asa SL; Ezzat S
Clin Cancer Res; 2008 Apr; 14(7):1984-96. PubMed ID: 18381936
[TBL] [Abstract][Full Text] [Related]
3. Epigenetically controlled fibroblast growth factor receptor 2 signaling imposes on the RAS/BRAF/mitogen-activated protein kinase pathway to modulate thyroid cancer progression.
Kondo T; Zheng L; Liu W; Kurebayashi J; Asa SL; Ezzat S
Cancer Res; 2007 Jun; 67(11):5461-70. PubMed ID: 17545628
[TBL] [Abstract][Full Text] [Related]
4. FGFR2 isoforms support epithelial-stromal interactions in thyroid cancer progression.
Guo M; Liu W; Serra S; Asa SL; Ezzat S
Cancer Res; 2012 Apr; 72(8):2017-27. PubMed ID: 22345151
[TBL] [Abstract][Full Text] [Related]
5. Melanoma associated antigen (MAGE)-A3 promotes cell proliferation and chemotherapeutic drug resistance in gastric cancer.
Xie C; Subhash VV; Datta A; Liem N; Tan SH; Yeo MS; Tan WL; Koh V; Yan FL; Wong FY; Wong WK; So J; Tan IB; Padmanabhan N; Yap CT; Tan P; Goh LK; Yong WP
Cell Oncol (Dordr); 2016 Apr; 39(2):175-86. PubMed ID: 26868260
[TBL] [Abstract][Full Text] [Related]
6. Promoter demethylation and histone acetylation mediate gene expression of MAGE-A1, -A2, -A3, and -A12 in human cancer cells.
Wischnewski F; Pantel K; Schwarzenbach H
Mol Cancer Res; 2006 May; 4(5):339-49. PubMed ID: 16687489
[TBL] [Abstract][Full Text] [Related]
7. The melanoma-associated antigen A3 mediates fibronectin-controlled cancer progression and metastasis.
Liu W; Cheng S; Asa SL; Ezzat S
Cancer Res; 2008 Oct; 68(19):8104-12. PubMed ID: 18829569
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic silencing through DNA and histone methylation of fibroblast growth factor receptor 2 in neoplastic pituitary cells.
Zhu X; Lee K; Asa SL; Ezzat S
Am J Pathol; 2007 May; 170(5):1618-28. PubMed ID: 17456767
[TBL] [Abstract][Full Text] [Related]
9. Intratumor heterogeneity of cancer/testis antigens expression in human cutaneous melanoma is methylation-regulated and functionally reverted by 5-aza-2'-deoxycytidine.
Sigalotti L; Fratta E; Coral S; Tanzarella S; Danielli R; Colizzi F; Fonsatti E; Traversari C; Altomonte M; Maio M
Cancer Res; 2004 Dec; 64(24):9167-71. PubMed ID: 15604288
[TBL] [Abstract][Full Text] [Related]
10. Decitabine enhances tumor recognition by T cells through upregulating the MAGE-A3 expression in esophageal carcinoma.
Shi X; Chen X; Fang B; Ping Y; Qin G; Yue D; Li F; Yang S; Zhang Y
Biomed Pharmacother; 2019 Apr; 112():108632. PubMed ID: 30797153
[TBL] [Abstract][Full Text] [Related]
11. Epigenetically regulated clonal heritability of CTA expression profiles in human melanoma.
Fratta E; Sigalotti L; Colizzi F; Covre A; Nicolay HJ; Danielli R; Fonsatti E; Altomonte M; Calabrò L; Coral S; Maio M
J Cell Physiol; 2010 May; 223(2):352-8. PubMed ID: 20127705
[TBL] [Abstract][Full Text] [Related]
12. Potential role of 5-aza-2'-deoxycytidine induced MAGE-A4 expression in immunotherapy for anaplastic thyroid cancer.
Gunda V; Cogdill AP; Bernasconi MJ; Wargo JA; Parangi S
Surgery; 2013 Dec; 154(6):1456-62; discussion 1462. PubMed ID: 24238058
[TBL] [Abstract][Full Text] [Related]
13. Genetic and epigenetic mechanisms down-regulate FGF receptor 2 to induce melanoma-associated antigen A in breast cancer.
Zhu X; Asa SL; Ezzat S
Am J Pathol; 2010 May; 176(5):2333-43. PubMed ID: 20348248
[TBL] [Abstract][Full Text] [Related]
14. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
15. Reduced expression of fibroblast growth factor receptor 2IIIb in hepatocellular carcinoma induces a more aggressive growth.
Amann T; Bataille F; Spruss T; Dettmer K; Wild P; Liedtke C; Mühlbauer M; Kiefer P; Oefner PJ; Trautwein C; Bosserhoff AK; Hellerbrand C
Am J Pathol; 2010 Mar; 176(3):1433-42. PubMed ID: 20093481
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of histone lysine methylation enhances cancer-testis antigen expression in lung cancer cells: implications for adoptive immunotherapy of cancer.
Rao M; Chinnasamy N; Hong JA; Zhang Y; Zhang M; Xi S; Liu F; Marquez VE; Morgan RA; Schrump DS
Cancer Res; 2011 Jun; 71(12):4192-204. PubMed ID: 21546573
[TBL] [Abstract][Full Text] [Related]
17. The roles of FGF signaling in germ cell migration in the mouse.
Takeuchi Y; Molyneaux K; Runyan C; Schaible K; Wylie C
Development; 2005 Dec; 132(24):5399-409. PubMed ID: 16291796
[TBL] [Abstract][Full Text] [Related]
18. Activation of melanoma antigen tumor antigens occurs early in lung carcinogenesis.
Jang SJ; Soria JC; Wang L; Hassan KA; Morice RC; Walsh GL; Hong WK; Mao L
Cancer Res; 2001 Nov; 61(21):7959-63. PubMed ID: 11691819
[TBL] [Abstract][Full Text] [Related]
19. Aberrantly enhanced melanoma-associated antigen (MAGE)-A3 expression facilitates cervical cancer cell proliferation and metastasis via actuating Wnt signaling pathway.
Gao X; Chen G; Cai H; Wang X; Song K; Liu L; Qiu T; He Y
Biomed Pharmacother; 2020 Feb; 122():109710. PubMed ID: 31918280
[TBL] [Abstract][Full Text] [Related]
20. Tumor-specific isoform switch of the fibroblast growth factor receptor 2 underlies the mesenchymal and malignant phenotypes of clear cell renal cell carcinomas.
Zhao Q; Caballero OL; Davis ID; Jonasch E; Tamboli P; Yung WK; Weinstein JN; ; Strausberg RL; Yao J
Clin Cancer Res; 2013 May; 19(9):2460-72. PubMed ID: 23444225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
